BACK | NEWS

IMeBIO will be present at South America’s leading healthcare💉💊🩸tradeshow together with its local partner BioSafe Brasil the market leader in the segment of #Biosafety #laboratories in #Brazil🇧🇷

🏥Hospitalar will take place from the 23rd to the 26th of May at the Sao Paulo Expo.
Subscribe to visithttps://lnkd.in/eCrTXm8

🚶‍♀️Visit our booth G-220 A in the French Pavilion 🇫🇷 and learn more about our complete offer in #biosafety and #biocontainment. 🚶‍♂️

French (IMeBIO) and Brazil’s (Biosafe) excellence in biosafety and biocontainment environments will be together at the HOSPITALAR tradeshow 2023.

The merger of complementary skills will offer wide solutions of biocontainment environments for all the customers in South America.

For more than 10 years IMeBIO has been designing and manufacturing mobile/modular solutions in maritime containers, we have installed more than 40 laboratories BSL2/BSL3 and GMP worldwide adapting our products to local conditions. As part of our after-sales service scope, we offer maintenance, tele maintenance, and qualification for laboratories.

Headquartered in Sao Paulo and present throughout the national territory, Biosafe Brazil, active since 2005 they are specialized and pioneers in consultancy, design, construction, maintenance, bio-decontamination, and certification of NB3-type environments.

www.biosafebrasil.com.br

🗓Book your one-to-one appointment here:
📧contact@imebio.com
📞+33 6 76 50 82 37

Latest news

16/03/2023 / France
IMeBIO 🏅55th in the top 500 of Les Echos "Champions of Growth 2023" ranking
We are pleased to announce that IMeBio has been listed in the "Champions of Growth 2023" ranking, obtaining the 55th place out of 500 an evolution of…
15/07/2022 / IMeBIO
IMeBIO labs are now present in Colombia!
IMeBIO labs are now present in Colombia with the 1st eDNA laboratory in the country.
06/05/2022 / IMeBIO
IMeBIO labs contributing to the Food Industry on behalf of Direct Analysis
On May 6, 2022, Direct Analysis inaugurated its arrival at Y.SPOT with the installation of the IMeBIO BSL-2 laboratory focused on the research and…